NCT00551720|CompletedPhase 3DMC
Motivation and Patch Treatment for HIV-positive Smokers
Positive PATHS
Loading search results
Sponsor study identifier
NIH
interventional
444
1 country
5
Study Start
January 1999
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
Not reported
Date not reportedStudy Completion
December 2004
Actual (reported)The purpose of this study is to develop and evaluate a brief, clinic-based smoking cessation treatment for an HIV+ population. We compared two treatments, a brief advice and follow-up plus nicotine patch treatment(Standard Care; SC) and brief advice and follow-up, nicotine patch, with the addition of a tailored motivational intervention and behavioral skills counseling for smoking cessation (Motivationally-Enhanced; ME), in a randomized controlled trial. We hypothesized that those HIV+ participants receiving the ME will demonstrate greater biochemically verified smoking abstinence rates at 6-month follow-up than those receiving the SC control treatment. All study participants were offered use of the nicotine patch.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 2004
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 1999
Date type not reportedThis date has not been verified as actual or estimated.
December 2004
Actual (reported)October 30, 2007
Actual (reported)October 31, 2007
Actual (reported)smoking cessation
6-months
smoking cessation
2- and 4-months
Brief advice and follow-up provided a smoking-cessation trained Health Educator PLUS nicotine patch
Brief advice and follow-up, nicotine patch, and the addition of a tailored motivational intervention and behavioral skills counseling for smoking cessation.
Stanley Street Treatment and Resources, Inc.
Fall River, Massachusetts, 02720, United States
Greater New Bedford Community Center
New Bedford, Massachusetts, 02740, United States
Hope Center for HIV Care, Memorial Hospital
Pawtucket, Rhode Island, 02906, United States
Rhode Island Hospital HIV Clinic
Providence, Rhode Island, 02903, United States
The Miriam Hospital Immunology Clinic
Providence, Rhode Island, 02906, United States
Mdege ND, Shah S, Dogar O, Pool ER, Weatherburn P, Siddiqi K, Zyambo C, Livingstone-Banks J. Interventions for tobacco use cessation in people living with HIV. Cochrane Database Syst Rev. 2024 Aug 5;8(8):CD011120. doi: 10.1002/14651858.CD011120.pub3.
Lloyd-Richardson EE, Stanton CA, Papandonatos GD, Shadel WG, Stein M, Tashima K, Flanigan T, Morrow K, Neighbors C, Niaura R. Motivation and patch treatment for HIV+ smokers: a randomized controlled trial. Addiction. 2009 Nov;104(11):1891-900. doi: 10.1111/j.1360-0443.2009.02623.x. Epub 2009 Aug 28.
Raymond Niaura, PhD
Brown University-Butler Hospital
Elizabeth Lloyd-Richardson, PhD
Brown University/The Miriam Hospital
444 participants (actual enrollment reported by the registry).
First Submitted
October 30, 2007
First Posted
October 31, 2007
Study Start
January 1999
Date type not reportedThis date has not been verified as actual or estimated.
A Comparison of Emtricitabine and Abacavir Used in a Three-Drug Combination in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
Study Completion
December 2004
Actual (reported)Last Updated
January 12, 2017
Record last verified: 2007-10
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: